# AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors

> **NCT01362803** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **National Cancer Institute (NCI)** · enrollment: 99 (actual)

## Conditions studied

- Neurofibromatosis 1
- Neurofibromatosis Type 1
- NF1
- Neurofibroma, Plexiform

## Interventions

- **DRUG:** AZD6244

## Key facts

- **NCT ID:** NCT01362803
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2011-09-21
- **Primary completion:** 2027-01-01
- **Final completion:** 2032-01-01
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01362803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01362803, "AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01362803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*